June 19, 2002
About 90% of patients with migraine or chronic daily headache had significant improvement in symptoms after four treatments of botulinum toxin A (Botox), according to a presentation on June 18 at the American Headache Society annual meeting held in Seattle, Washington. Because Botox can be less expensive and have fewer adverse effects than many medications used for headache prevention, this approach could substantially reduce both the morbidity and the cost of managing chronic headache.
“Botox is becoming one of the main preventive therapies for headache,” presenter B. Todd Troost, MD, from Wake Forest University Baptist Medical Center in Winston-Salem, N.C., says in a news release. “When it is effective, the need for daily medications or acute medicines for severe attacks is significantly reduced or eliminated.”
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!